Posted inGenetics
J&J to Acquire Intra-Cellular for $14.6B
Johnson & Johnson has agreed to acquire Intra-Cellular Therapies for approximately $14.6 billion, the companies said today, in the largest…
Posted inBiotechnology
Breaking Down Barriers: An Integrated Approach to Achieving Sustainable Food Systems
In an era where the importance of sustainable diets is increasingly recognized, the persistent challenges that hinder access to healthy…
Posted inBiotechnology
Mayo Clinic Introduces Digital Pathology Initiative to Revolutionize the Field and Accelerate Medical Advancements
ROCHESTER, Minn. — The Mayo Clinic has taken a significant leap into the future of medical diagnostics by unveiling its…
Posted inBiotechnology
Integrated Care Enhances Smoking Cessation Success: The Role of Medication and Counseling
HOUSTON — A recent study conducted by researchers at The University of Texas MD Anderson Cancer Center reveals that smokers…
Posted inBiotechnology
Focused Strategies to Modify Bacterial Metabolism
Bacterial infections present a growing challenge to public health, particularly as antibiotic resistance becomes increasingly prevalent across the globe. Recent…
Posted inBiotechnology
Scientists Create ‘Malteser-Inspired’ Molecules for Potential Targeted Drug Delivery Innovations
Scientists affiliated with Trinity College Dublin have achieved a significant milestone in the field of chemistry, addressing one of the…
Posted inBiotechnology
From Tiny Particles to Major Challenges: KTU Expert Discusses the Hurdles of Plastic Recycling
In recent years, the looming crisis of plastic waste has rapidly ascended to the forefront of environmental concerns. With microplastic…
Posted inGenetics
Iconovo and Lonza Agree to Collaborate on the Formulation Development of an Intranasal Biologic
Iconovo, which develops inhalable drugs based on proprietary inhalers and dry powder formulations, reports that it and Lonza initiated a…
Posted inBiotechnology
JPM25: Roche has access to $10B in M&A firepower per year, pharma CEO says. Where will it spend the money?
Roche has about $10 billion in M&A firepower it can deploy every year, but it’s “not just going to spend…
Posted inBiotechnology
NUS Medicine Research Reveals Brain Connectome Phenotype Associated with Cerebrovascular Disease as a Predictor of Cognitive Decline
Researchers at the National University of Singapore have made groundbreaking discoveries in understanding how cerebrovascular disease (CeVD) interacts with Alzheimer’s…